Neil Andrew Goldenberg

Dr. Neil Andrew Goldenberg is a distinguished Professor of Pediatrics at Johns Hopkins All Children's Hospital, where he plays a pivotal role in advancing pediatric research. As the Associate Dean for Research, Director of the Johns Hopkins All Children's Institute for Clinical and Translational Research, and Chief Research Officer, he is at the forefront of innovative research initiatives. His primary research interests lie in pediatric thrombosis and stroke, areas in which he has made significant contributions through his work. Dr. Goldenberg's academic journey began at McGill University, where he earned his medical degree. He further honed his clinical skills during his residency at the University of South Florida. His pursuit of excellence in research led him to obtain a Ph.D. in clinical investigation from the University of Colorado Health Sciences Center, equipping him with the expertise to lead groundbreaking studies in his field. Throughout his career, Dr. Goldenberg has been the recipient of numerous grants, including those from the National Institutes of Health (NIH) and the American Society of Hematology (ASH), underscoring the impact and importance of his research. His work has been instrumental in advancing the understanding and treatment of pediatric thrombosis and stroke, contributing to improved outcomes for young patients. Before his tenure at Johns Hopkins, Dr. Goldenberg was a faculty member at the University of Colorado School of Medicine. There, he demonstrated exceptional leadership as the head of the Children's Clinical Research Organization and the Pediatric Thrombosis and Stroke Programs at Children's Hospital Colorado. His efforts in these roles laid the groundwork for his continued success in pediatric research. Dr. Goldenberg's dedication to his field is reflected in his numerous publications and presentations at national and international conferences. His work not only advances scientific knowledge but also translates into tangible benefits for children affected by thrombosis and stroke. Through his leadership and research, Dr. Goldenberg remains committed to improving the lives of pediatric patients and shaping the future of pediatric medicine.